Understanding the Eczema Area and Severity Index
The EASI score represents a standardized clinical tool for quantifying atopic dermatitis burden. Unlike subjective descriptions, it produces a numerical rating that allows meaningful comparisons over time and across different treatment approaches.
The scale ranges from 0 (no visible disease) to 72 (most severe disease). A score of 0 means your skin appears normal with no inflammatory changes. At the opposite end, a score above 51 indicates very severe atopic dermatitis requiring aggressive medical intervention.
The index separates assessment into two components:
- Area component: The percentage of skin affected in each body region (head/neck, trunk, upper limbs, lower limbs)
- Severity component: The intensity of four signs—redness, thickness/swelling, scratching, and lichenification
This dual approach ensures that treatment decisions account for both widespread mild disease and focal severe manifestations. A small area with intense inflammation may warrant similar urgency as a large area with mild changes.
The EASI Score Formula
The calculation involves two stages. First, you determine the severity score for each body region by summing the intensity ratings of redness, thickness, scratching, and lichenification. Each symptom is rated 0 (none) to 3 (severe).
Next, multiply that severity total by the affected surface area percentage and a weighting factor specific to each body region. The weighting accounts for how much that region typically contributes to overall disease burden.
Finally, add the four regional scores to obtain your total EASI score.
Head & Neck Score = Severity × Area % × (0.1 if age ≥8, else 0.2)
Trunk Score = Severity × Area % × 0.3
Upper Limbs Score = Severity × Area % × 0.2
Lower Limbs Score = Severity × Area % × (0.3 if age ≥8, else 0.4)
EASI Score = Head & Neck + Trunk + Upper Limbs + Lower Limbs
Severity— Sum of redness, thickness, scratching, and lichenification intensities (each rated 0–3)Area %— Percentage of skin surface affected in that body region (0–100%)Region Factor— Multiplier reflecting the proportion of total body surface each region represents; varies by age group
What Is Atopic Dermatitis?
Atopic dermatitis is a chronic inflammatory skin condition characterised by intense itching, dryness, and recurrent flares. It disrupts the skin barrier, allowing irritants and allergens to penetrate more easily, which perpetuates inflammation and symptoms.
The condition often begins in childhood—typically before age 5—though it can emerge at any point in life. Many patients experience improvement after adolescence, yet others contend with flares throughout adulthood. The disease frequently co-occurs with asthma and allergic rhinitis, suggesting shared immune dysfunction.
Common features include:
- Severe itching, often worse at night
- Dry, sensitive, easily irritated skin
- Visible scaling and lichenification (thickened, leathery patches)
- Erythema (redness) and oedema (swelling)
- Secondary bacterial colonisation from scratching
EASI scoring helps clinicians stratify disease severity and track whether interventions—topical steroids, calcineurin inhibitors, biologic therapies—are achieving meaningful improvement.
Interpreting Your EASI Score
Once calculated, your score falls into one of five severity bands, each requiring different clinical approaches:
- 0: No eczema. Skin barrier is intact and no inflammatory signs are present.
- 0.1–1.0: Almost clear. Minimal residual activity; most people would not recognise eczema on inspection.
- 1.1–7.0: Mild. Some visible changes and occasional symptoms, but inflammation is limited and does not significantly impair function.
- 7.1–21.0: Moderate. Noticeable redness, swelling, and itching that may affect sleep or daily activities.
- 21.1–50.0: Severe. Widespread or intensely inflamed lesions with significant impact on quality of life; urgent medical evaluation advised.
- 51.1–72.0: Very severe. Extensive disease requiring specialist care and potentially systemic therapy.
A single EASI measurement provides a snapshot, but serial measurements over weeks or months reveal whether your treatment regimen is effective. A falling score indicates clinical improvement; a rising score signals need for treatment adjustment.
Key Considerations When Using the EASI Score
The EASI score is a powerful assessment tool, but several practical points ensure accurate and meaningful results.
- Distinguish affected from normal skin carefully — EASI relies on honest estimation of the percentage of affected skin. If you have scattered small plaques, estimate their combined area accurately. Overestimating or underestimating the extent can shift your score by several points, potentially leading to inappropriate treatment intensity.
- Rate severity components independently — Redness, thickness, scratching, and lichenification may not correlate perfectly. You can have intense itching with minimal visible redness, or significant lichenification with mild itching. Assess each component separately using the provided visual reference, not your overall impression of severity.
- Account for treatment timing — EASI scores taken just after starting potent topical steroid therapy may not reflect your true baseline or steady-state disease. Ideally, obtain scores when treatment is stable, or note the timing when comparing sequential measurements to account for acute flares.
- Remember age-dependent weighting factors — The multipliers for head/neck and lower limbs differ for children under 8 years old versus older individuals. Using the wrong factor will produce an inaccurate score. Confirm your patient's age category before calculation.